Source: Eur Respir J 2003; 22: 57S-64S
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Meduri G.U., Carratu P., Freire A.X.. Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS. Eur Respir J 2003; 22: 57S-64S

Member's Comments

No comment yet.

Related content which might interest you: Variable tissue expression of transferrin receptors: relevance to acute respiratory distress syndrome Source: Eur Respir J 2003; 22: 335-341 Year: 2003 The impact of two partial ventilatory support modalities on lung histology and inflammatory mediators in a model of acute respiratory distress syndrome Source: Annual Congress 2007 - Acute lung injury and inflammation Year: 2007 Angiopoietin like 4 as a clinical biomarker for acute respiratory distress syndrome Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019 The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance Source: Eur Respir J 2014; 43: 276-285 Year: 2004 Prospects for pharmacotherapy in acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=247 Year: 2002 Epidemiology and prognosis of acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=1 Year: 2002 Combined cell therapy and anticoagulants for acute respiratory distress syndrome Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management Year: 2006 Surfactant therapy in acute lung injury/acute respiratory distress syndrome Source: Eur Respir Mon 2012; 55: 54-64 Year: 2012 Mechanisms of acute lung injury Source: Annual Congress 2005 - In vivo - approaches to lung injury Year: 2005 Glucocorticoid receptor-binding characteristics in severe asthma Source: Eur Respir J 2003; 21: 985-988 Year: 2003 Time course of serum leptin and markers of systemic inflammation during acute hypercapnic respiratory failure in patients with COPD and obesity-hypoventilation syndrome (OHS) Source: Eur Respir J 2006; 28: Suppl. 50, 394s Year: 2006 Neuregulin-1 as a potentially novel biomarker in acute respiratory distress syndrome Source: Eur Respir J 2013; 41: 259-261 Year: 2013 Drug-induced ILD Source: Annual Congress 2007 - PG5 - Interstitial lung diseases: known causes and systemic disorders Year: 2007 Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome Source: Eur Respir J 2009; 33: 543-550 Year: 2009 Exogenous pulmonary surfactant administration for acute respiratory distress syndrome in post-operative patients Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 A respiratory perspective on long term beta-blocker treatment in patients presenting with acute cardiac disease Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010 Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome Source: Eur Respir Rev, 29 (156) 200114; 10.1183/16000617.0114-2020 Year: 2020 Current invasive ventilatory strategies in acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=161 Year: 2002 COVID-19 patient with acute respiratory distress syndrome (ARDS) benefit most from an early prone position Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure Year: 2021